Table 2.
Previously used preventive medication before starting a monoclonal antibody including the reason for discontinuing the treatment
| Non-Responder | Side Effects | Loss-of-Efficacy | Other | Total | |
|---|---|---|---|---|---|
| Beta-Blocker | 48 (57.1) | 18 (21.4) | 7 (8.3) | 11 (13.1) | 84 (49.1) |
| Topiramate | 35 (41.7) | 36 (42.9) | 5 (6.0) | 8 (9.5) | 84 (49.1) |
| Flunarizine | 29 (46.8) | 21 (33.9) | 3 (4.8) | 9 (14.5) | 62 (36.3) |
| Amitriptyline | 38 (59.4) | 15 (23.4) | 1 (1.6) | 10 (15.6) | 64 (37.4) |
| OnabotulinumtoxinA | 17 (85.0) | 1 (5.0) | - | 2 (10.0) | 20 (11.7) |
| Valproic acid | 10 (55.6) | 5 (27.8) | 2 (11.1) | 1 (5.6) | 18 (10.5) |
| Candesartan | 5 (62.5) | - | - | 3 (37.5) | 8 (4.7) |
| Venlafaxine | 4 (57.1) | 0 (0.0) | - | 3 (42.9) | 7 (4.1) |
| Tanacetum parthenium | 6 (85.7) | - | - | 1 (14.3) | 7 (4.1) |
| Other | 23 (65.7) | 4 (11.4) | - | 8 (22.9) | 35 (20.5) |
Values are absolute numbers and percent (%)